Cargando…

Gastrointestinal Stromal Tumours treated before and after the advent of c-kit immunostaining

BACKGROUND: Recently developed immunohistochemical markers have revolutionised the classification of gastrointestinal stromal tumours (GISTs) whilst tyrosine kinase inhibitors (imatinib) have had a significant impact on the treatment of advanced tumours. We review the clinicopathological features of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorelli, Paolo G, Cohen, Patrizia, Amo-Takyi, Bafour, Theodorou, Nikitas A, Dawson, Peter M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111356/ https://www.ncbi.nlm.nih.gov/pubmed/21524289 http://dx.doi.org/10.1186/1477-7819-9-44

Ejemplares similares

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
por: Huang, Mengyuan, et al.
Publicado: (2019)

Morphological Correlates of KIT and PDGFRA Genotypes in Gastrointestinal Stromal Tumour
por: Priya, Valli, et al.
Publicado: (2020)

ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
por: Gromova, Petra, et al.
Publicado: (2012)

Stromal Filters in Automated Immunostain Scoring
por: Patel, Kunal, et al.
Publicado: (2014)

Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism
por: Théou-Anton, N, et al.
Publicado: (2006)

Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression
por: Ostrowski, Jerzy, et al.
Publicado: (2009)

THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
por: Sun, Jianyi, et al.
Publicado: (2022)

Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
por: Xu, Zhi, et al.
Publicado: (2014)

C-Kit-Negative Gastrointestinal Stromal Tumor in the Stomach
por: Seo, Ho Seok, et al.
Publicado: (2015)

Immunostaining of stromal CD56 cells in ovarian malignancies
por: de Lima, Cid Almeida, et al.
Publicado: (2023)

Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation
por: Wakai, T, et al.
Publicado: (2004)

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
por: Serrano, César, et al.
Publicado: (2019)

Advent of Elkosin
por: Banerji, Binoy
Publicado: (1950)

Gastrointestinal Stromal Tumours: An Update
por: Somerhausen, Nicolas De Saint Aubain, et al.
Publicado: (1998)

Ripretinib for gastrointestinal stromal tumours
Publicado: (2021)

Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1
por: Namgung, Hwan
Publicado: (2011)

Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
por: Caenepeel, Sean, et al.
Publicado: (2010)

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
por: Katz, Steven C, et al.
Publicado: (2013)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors
por: Suehara, Yoshiyuki, et al.
Publicado: (2018)

Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors
por: Gao, Jing, et al.
Publicado: (2016)

A Proposal for Formation of Archaean Stromatolites before the Advent of Oxygenic Photosynthesis
por: Allen, John F.
Publicado: (2016)

The Advent of Domain Adaptation into Artificial Intelligence for Gastrointestinal Endoscopy and Medical Imaging
por: Kim, Min Ji, et al.
Publicado: (2023)

KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
por: Joensuu, Heikki
Publicado: (2023)

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
por: Serrano, César, et al.
Publicado: (2019)

TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
por: Saito, Yurina, et al.
Publicado: (2019)

Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours
por: Liu, Juan, et al.
Publicado: (2022)

The role of [(68) Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)
por: Aloj, Luigi, et al.
Publicado: (2021)

Spectrum of the KIT Gene Mutations in Gastrointestinal Stromal Tumors in Arab Patients
por: Faiyaz-Ul-Haque, Muhammad, et al.
Publicado: (2018)

KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors
por: Palomba, Grazia, et al.
Publicado: (2020)

Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
por: Jiang, Lili, et al.
Publicado: (2021)

The adventive flora of Tweedside
por: Hayward, Ida M.
Publicado: (1919)

The Advent of Lifestyle Medicine
por: Yeh, Byung-Il, et al.
Publicado: (2013)

The Advent of Colloidal Alkaloids
Publicado: (1917)

The Advent of Old Age
Publicado: (1873)

Second Advent of Thomsonism
Publicado: (1848)

Quantitative observations of fever and its treatment before the advent of short clinical thermometers.
por: Estes, J W
Publicado: (1991)

Gastrointestinal stromal tumour in Meckel's diverticulum
por: Chandramohan, K, et al.
Publicado: (2007)

The radiology of gastrointestinal stromal tumours (GIST)
por: Michael King, D
Publicado: (2005)

Primary mesenteric gastrointestinal stromal tumour
por: Kirby, R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_045nb7upitbencpo96739u7njq